CVS will change the way it prices prescription drugs
CVS is overhauling its pharmacy reimbursement model for prescription drugs, a strategic shift that aims to simplify drug pricing and potentially alter the costs borne by consumers. The company announced on Tuesday that its new pharmacy reimbursement model, named CVS CostVantage, seeks to introduce transparency into its drug pricing system. This model, slated to launch for commercial payors in 2025, shares similarities with the approach advocated by entrepreneur Mark Cuban through his Cost Plus Drugs company. A Predetermined Markup for prescription drugs The current pricing dynamics for drugs involve complex reimbursement formulas influenced by pharmacy benefit managers negotiating rebates from drug manufacturers to insurers. This intricate process does not directly correlate with the actual expenses incurred by pharmacies to procure specific drugs. CVS’s new approach involves a simplified formula, encompassing the drug’s cost, a predetermined markup, and a fee t...